Company / Book Value per Share
IOVANCE BIOTHERAPEUTICS, INC. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.289
FY2025
5-year range
$2.289 / $4.1K
FY2021-FY2025
Trend
-17.5%
vs FY2024
Sector context
#143 of 209
Health Care
What the data says
At $2.289, IOVANCE BIOTHERAPEUTICS, INC.'s book value per share ranks #143 of 209 in the Health Care sector. Book Value per Share has declined for 5 consecutive years, from $4,746.878 in FY2020 to $2.289 in FY2025.
Based on SEC 10-K filings.
$2.289 in FY2025 with a 5-year CAGR of -78.3%.
Declined from $3.113 to $2.289 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -91.0%
- 5-Year CAGR
- -78.3%
- 10-Year CAGR
- -
Sector benchmark
#143 of 209 in Health CareTop 68% of 209This company $2.289 Sector average $215.686
▼
-98.9% below sector average
Key checks
Key Insights
- IOVANCE BIOTHERAPEUTICS, INC.'s book value per share has declined for 5 consecutive years.
- 5-year CAGR of -78.3%, indicating a declining trend.
- In FY2025, book value per share decreased 17.5% year-over-year.
- Ranks #143 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.289 | -17.5% |
| FY2024 | $2.774 | -10.9% |
| FY2023 | $3.113 | -99.9% |
| FY2022 | $3.1K | -22.6% |
| FY2021 | $4.1K | -14.6% |
| FY2020 | $4.7K | +97.4% |
| FY2019 | $2.4K | +37637.2% |
| FY2018 | $6.372 | +172.6% |
| FY2017 | $2.337 | +153.0% |
| FY2016 | $0.924 | +77.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026